Cheryl R. Blanchard - 14 Mar 2026 Form 4 Insider Report for Anika Therapeutics, Inc. (ANIK)

Role
Director
Signature
/s/ Cheryl R. Blanchard
Issuer symbol
ANIK
Transactions as of
14 Mar 2026
Net transactions value
$0
Form type
4
Filing time
17 Mar 2026, 19:42:01 UTC
Previous filing
11 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Blanchard Cheryl R Director C/O ANIKA THERAPEUTICS, INC., 32 WIGGINS AVENUE, BEDFORD /s/ Cheryl R. Blanchard 17 Mar 2026 0001326530

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIK Common Stock Options Exercise +24,519 +12% 235,969 14 Mar 2026 Direct F1
transaction ANIK Common Stock Award +24,520 +10% $0.000000* 260,489 14 Mar 2026 Direct F2
transaction ANIK Common Stock Tax liability -14,728 -5.7% $14.20* 245,761 14 Mar 2026 Direct F3
transaction ANIK Common Stock Options Exercise +25,131 +10% 270,892 15 Mar 2026 Direct F1
transaction ANIK Common Stock Tax liability -12,104 -4.5% $14.20* 258,788 15 Mar 2026 Direct F4
holding ANIK Common Stock 11,742 14 Mar 2026 Revocable Trust F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANIK Restricted Stock Unit Options Exercise -24,519 -33% $0.000000* 49,040 14 Mar 2026 Common Stock 24,519 Direct F1, F6
transaction ANIK Restricted Stock Unit Options Exercise -25,131 -50% $0.000000* 25,132 15 Mar 2026 Common Stock 25,131 Direct F1, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents the contingent right to receive one share of Issuer common stock.
F2 On March 14, 2025, the Reporting Person was granted 73,559 performance-based phantom RSUs ("PSUs") with vesting contingent upon the achievement of pre-established performance and strategic targets. This transaction represents the first vesting installment of such PSU award.
F3 Reflects an aggregate of 14,728 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs and PSUs that vested on March 14, 2026.
F4 Reflects an aggregate of 12,104 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 15, 2026.
F5 Consists of shares held by The Cheryl R. Blanchard Amended and Restated Revocable Trust dated December 19, 2014, of which the Reporting Person is a beneficiary and the sole trustee.
F6 On March 14, 2025, the Reporting Person was granted 73,559 RSUs vesting in three equal annual installments beginning on March 14, 2026. This transaction reflects the first vesting installment of such RSU award.
F7 On March 15, 2024, the Reporting Person was granted 75,395 RSUs vesting in three equal annual installments beginning on March 15, 2025. This transaction reflects the second vesting installment of such RSU award.